Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Nutex Health (NUTX) over the last 17 years, with Q3 2025 value amounting to -$302000.0.

  • Nutex Health's Cash from Investing Activities fell 1310.86% to -$302000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.5 million, marking a year-over-year decrease of 14964.51%. This contributed to the annual value of -$5.6 million for FY2024, which is 5012.39% up from last year.
  • Per Nutex Health's latest filing, its Cash from Investing Activities stood at -$302000.0 for Q3 2025, which was down 1310.86% from $196000.0 recorded in Q2 2025.
  • In the past 5 years, Nutex Health's Cash from Investing Activities ranged from a high of $7.9 million in Q4 2022 and a low of -$25.6 million during Q2 2021
  • For the 5-year period, Nutex Health's Cash from Investing Activities averaged around -$3.1 million, with its median value being -$1.3 million (2024).
  • Within the past 5 years, the most significant YoY rise in Nutex Health's Cash from Investing Activities was 14649559.49% (2021), while the steepest drop was 670629.72% (2021).
  • Over the past 5 years, Nutex Health's Cash from Investing Activities (Quarter) stood at -$11.8 million in 2021, then surged by 166.95% to $7.9 million in 2022, then tumbled by 89.02% to $865599.0 in 2023, then crashed by 485.4% to -$3.3 million in 2024, then surged by 90.95% to -$302000.0 in 2025.
  • Its Cash from Investing Activities was -$302000.0 in Q3 2025, compared to $196000.0 in Q2 2025 and -$64000.0 in Q1 2025.